BM BC Moly Ltd

BacTech Mining Corporation ("BacTech" or the "Company")(TSX VENTURE:BM) today
announced that it has increased the amount of its proposed financing to $850,000
due to increased investor demand.


BacTech announced on February 18, 2010, that it planned to sell a 22.5% interest
in its wholly-owned subsidiary, BacTech Gold Corporation, to outside investors
for $750,000. The increase in the financing will now result in BacTech selling
25.5% of the subsidiary.


Pursuant to the financing transaction, BacTech will now issue 850 Subscription
Receipts at a price of $1,000 each, to raise gross proceeds of $850,000. Upon
completion of the Reorganization, the Subscription Receipts will be
automatically exchanged for that number of BGC Shares which will represent 25.5%
of the outstanding BGC Shares immediately after the transaction (which number is
expected to be approximately 10.25 million BGC Shares), together with 8.5
million warrants of BGC (the "BGC Warrants"). Each BGC Warrant will be
exercisable for one BGC Share at a price of $0.10 per share for 18 months.
BacTech will also pay to the holders of the Subscription Receipts interest at
the rate of 10% per annum for the period from the date of closing of the
Subscription Receipt financing to the effective date of the Reorganization. In
the event the Reorganization is not completed within six months, BacTech will be
obligated to repay the subscription price for the Subscription Receipts,
together with interest at the rate of 10% per annum, and issue to the holders an
aggregate of 6,800,000 BacTech warrants exercisable at $0.10 per share for 18
months.


BACTECH PROFILE

BacTech owns patented bacterial oxidation technology for the treatment of
refractory ores and concentrates to enhance the recovery of gold, silver and
base metals. The Company's focus is the acquisition of equity positions in
projects amenable to bioleaching. In January the Company announced its intention
to effect a divisive reorganization whereby BacTech will transfer all of its
interests in mining projects and the rights to its bioleaching technology to a
wholly-owned subsidiary. The common shares of the subsidiary will be distributed
to the shareholders of BacTech upon completion of the reorganization. BacTech
will hold an exclusive and perpetual right to use the bioleaching technology for
projects related to environmental remediation of mine tailings.


Shares outstanding 89,264,706

BC Moly (TSXV:BM)
Historical Stock Chart
From Jun 2024 to Jul 2024

BC Moly (TSXV:BM)
Historical Stock Chart
From Jul 2023 to Jul 2024